BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 7518468)

  • 1. Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
    Landis RC; McDowall A; Holness CL; Littler AJ; Simmons DL; Hogg N
    J Cell Biol; 1994 Jul; 126(2):529-37. PubMed ID: 7518468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway.
    Campanero MR; del Pozo MA; Arroyo AG; Sánchez-Mateos P; Hernández-Caselles T; Craig A; Pulido R; Sánchez-Madrid F
    J Cell Biol; 1993 Nov; 123(4):1007-16. PubMed ID: 7901223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel LFA-1 activation epitope maps to the I domain.
    Landis RC; Bennett RI; Hogg N
    J Cell Biol; 1993 Mar; 120(6):1519-27. PubMed ID: 7680657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.
    Cabañas C; Hogg N
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5838-42. PubMed ID: 7685913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow.
    Knorr R; Dustin ML
    J Exp Med; 1997 Aug; 186(5):719-30. PubMed ID: 9271587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1.
    Binnerts ME; van Kooyk Y; Simmons DL; Figdor CG
    Eur J Immunol; 1994 Sep; 24(9):2155-60. PubMed ID: 7916295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
    Stanley P; McDowall A; Bates PA; Brashaw J; Hogg N
    Biochem J; 2000 Oct; 351(Pt 1):79-86. PubMed ID: 10998349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the binding site on intercellular adhesion molecule-3 (ICAM-3) for lymphocyte function-associated antigen 1 (LFA-1).
    Klickstein LB; York MR; Fougerolles AR; Springer TA
    J Biol Chem; 1996 Sep; 271(39):23920-7. PubMed ID: 8798624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1).
    Edwards CP; Champe M; Gonzalez T; Wessinger ME; Spencer SA; Presta LG; Berman PW; Bodary SC
    J Biol Chem; 1995 May; 270(21):12635-40. PubMed ID: 7539005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ligands in the activation of LFA-1.
    Buckley CD; Ferguson ED; Littler AJ; Bossy D; Simmons DL
    Eur J Immunol; 1997 Apr; 27(4):957-62. PubMed ID: 9130650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LFA-1 binding site in ICAM-3 contains a conserved motif and non-contiguous amino acids.
    Sadhu C; Lipsky B; Erickson HP; Hayflick J; Dick KO; Gallatin WM; Staunton DE
    Cell Adhes Commun; 1994 Oct; 2(5):429-40. PubMed ID: 7531103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I domain of beta 2 integrin lymphocyte function-associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1.
    Randi AM; Hogg N
    J Biol Chem; 1994 Apr; 269(17):12395-8. PubMed ID: 7909800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses.
    de Fougerolles AR; Qin X; Springer TA
    J Exp Med; 1994 Feb; 179(2):619-29. PubMed ID: 7905020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells.
    Starling GC; McLellan AD; Egner W; Sorg RV; Fawcett J; Simmons DL; Hart DN
    Eur J Immunol; 1995 Sep; 25(9):2528-32. PubMed ID: 7589121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands.
    Campanero MR; Sánchez-Mateos P; del Pozo MA; Sánchez-Madrid F
    J Cell Biol; 1994 Nov; 127(3):867-78. PubMed ID: 7525599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1).
    McDowall A; Leitinger B; Stanley P; Bates PA; Randi AM; Hogg N
    J Biol Chem; 1998 Oct; 273(42):27396-403. PubMed ID: 9765268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.
    Leitinger B; Hogg N
    Mol Biol Cell; 2000 Feb; 11(2):677-90. PubMed ID: 10679023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct.
    Driessens MH; van Hulten P; Zuurbier A; La Rivière G; Roos E
    J Leukoc Biol; 1996 Dec; 60(6):758-65. PubMed ID: 8975879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3.
    Bleijs DA; de Waal-Malefyt R; Figdor CG; van Kooyk Y
    Eur J Immunol; 1999 Jul; 29(7):2248-58. PubMed ID: 10427988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the intercellular adhesion molecule-1 and -2 binding site on the inserted domain of leukocyte function-associated antigen-1.
    Edwards CP; Fisher KL; Presta LG; Bodary SC
    J Biol Chem; 1998 Oct; 273(44):28937-44. PubMed ID: 9786897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.